Submission Slot Booking

Elevate your European Regulatory strategy with Freyr's MAA slot booking services. Our team provides comprehensive support for submission timeline management, Health Authority communications, and pre-submission preparations to accelerate your market access.

Submission Slot Booking - Overview

The Marketing Authorization Holder (MAH), planning to submit the MAA through any of the Regulatory procedures should check for available dates with the European Medicines Agency (EMA) or with a reference Member State to understand the submission timelines and get confirmation for the submission. The MAH should submit the MAA on the allotted slot to HAs. Delays in the submission should be communicated with HA well in advance. Slot booking should be performed a few months before the planned submission timelines. Freyr can help the MAHs with slot booking and do necessary correspondence with HAs for any required clarification.

Submission Slot Booking - Expertise

  • Booking of slots with a choice of RMS for marketing authorization application via slot booking process
  • Support in MAA Pre-submission meeting and pre-submission administrative activities including slot booking
  • Request the HA to act as RMS and book the slot for submission
  • Liaise with RMS in case of submission through DCP/MRP procedures
Submission Slot Booking

Celebrating Customers Success

 

Medicinal Products

Regulatory Affairs

India

Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified. This continuously demonstrates Freyr's commitment towards our company’s milestones.

Director - Global Regulatory Affairs – Operations

India-based, Global Top Generic Pharma Company

 

Medicinal Products

Publishing

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Sr. Director, Head of Regulatory Operations

Ireland-based, Global Specialty Pharmaceutical Company

 

Medicinal Products

Regulatory Affairs

USA

Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions: that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.

Thank you for always being available and responding quickly and comprehensively to all my requests.

What a great team you have, Freyr.

Lynne McGrath

Regulatory Consultant

 

Medicinal Products

Regulatory Affairs

USA

Congratulations!!! ​

Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.

Assistant Manager​

US-based, Leading, Complex Generic Pharmaceutical Products Company​

 

Medicinal Products

Regulatory Affairs

USA

Thank you all for the great support!​

CEO

US-based, Leading Innovative Pharmaceuticals Company​

 

Medicinal Products

Regulatory Affairs

USA

The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company. ​

Thank you again, and we look forward to working with your team on the next project!

Senior Director of Business and Product Development​

US-based, Leading Innovator Pharmaceuticals Company​